MedTrace Logo

The Efficiency of Colon Capsule Endoscopy in Colon Cancer Screening

NCT03052335 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2019-01-15

No results posted yet for this study

Summary

Main objective is to improve colorectal cancer (CRC) screening programme in the Czech Republic and decrease the disease incidence and mortality. The secondary aim is to verify the effectiveness of incorporation of the new minimally invasive device in the prevention programme.

Conditions

Interventions

DEVICE

Pillcam® COLON 2 Capsule

The second generation of PillCam colon capsule endoscopy (CCE-2) is 11.6 mm × 31.5 mm in size and has two imagers, that each have a 172° angle of view, allowing for almost 360° visual coverage of the colon. CCE-2 has an adaptive frame rate from 4 to 35 images per second. This means that the camera is able to capture up to 35 pictures while in motion whereas 4 images per second are captured when it is virtually stationary. During the examination the patient wears a sensor array which is attached to the abdomen and a data recorder for storage of the information generated by the ingested capsule. After the examination the data are downloaded into the workstation and a video is generated.

PROCEDURE

Colonoscopy

Optical colonoscopy is the standard method for evaluating the colon

Sponsors & Collaborators

  • Masaryk University

    collaborator OTHER

  • Institute for Clinical and Experimental Medicine

    collaborator OTHER_GOV

  • University Hospital Hradec Kralove

    collaborator OTHER

  • Military University Hospital, Prague

    lead OTHER

Principal Investigators

  • Stepan Suchanek · Military University Hospital, Prague

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03052335 on ClinicalTrials.gov